Shares of RTW Biotech Opportunities (LON:RTW – Get Free Report) traded down 0.4% during trading on Wednesday . The company traded as low as GBX 2.39 and last traded at GBX 2.40. Approximately 382,650 shares traded hands during mid-day trading, a decline of 53% from the average session volume of 806,257 shares. The stock had previously closed at GBX 2.41.
RTW Biotech Opportunities Stock Down 0.4%
The firm has a market capitalization of £7.75 million, a price-to-earnings ratio of 0.04 and a beta of 0.78. The business’s 50-day moving average is GBX 2.25 and its two-hundred day moving average is GBX 2.16. The company has a debt-to-equity ratio of 20.05, a quick ratio of 0.81 and a current ratio of 0.15.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
See Also
- Five stocks we like better than RTW Biotech Opportunities
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
